NeuroDx Development specializes in innovative medical devices aimed at enhancing neurosurgical practices, particularly through their flagship product, ShuntCheck©. This device employs non-invasive thermal dilution technology to assess fluid flow in cerebrospinal fluid (CSF) shunts. By providing a frontline rule-out test for potential obstructions, ShuntCheck© helps clarify ambiguous imaging results and can identify issues such as fractured or disconnected catheters. This capability is crucial for improving patient outcomes in pediatric neurosurgery, as it allows for timely interventions when shunt malfunction is suspected.

The company was founded by Dr. Samuel Neff, a neurosurgeon who recognized significant unmet needs within the neurosurgical field. NeuroDx Development is committed to advancing the understanding and management of CSF flow dynamics, thereby enhancing the safety and effectiveness of neurosurgical procedures. Their focus on research and development is underscored by their involvement in multi-center studies, which aim to validate the efficacy of ShuntCheck© in real-world clinical settings, ultimately contributing to better patient care and outcomes in neurosurgery.

United States

NeuroDx is a medical technology company that specializes in using non-invasive thermal dilution to detect fluid flow in CSF shunts.

NeuroDx Development

Company Details